AlphaQuest LLC Reduces Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

AlphaQuest LLC reduced its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 34.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,912 shares of the company’s stock after selling 3,669 shares during the quarter. AlphaQuest LLC’s holdings in Phibro Animal Health were worth $145,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in PAHC. Hussman Strategic Advisors Inc. purchased a new position in Phibro Animal Health during the 4th quarter valued at about $2,205,000. Jacobs Levy Equity Management Inc. increased its holdings in Phibro Animal Health by 116.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock valued at $4,330,000 after acquiring an additional 103,491 shares in the last quarter. Algert Global LLC increased its holdings in Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after acquiring an additional 59,850 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Phibro Animal Health during the fourth quarter worth about $1,103,000. Finally, Wakefield Asset Management LLLP purchased a new stake in shares of Phibro Animal Health during the fourth quarter worth about $1,020,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

PAHC opened at $21.85 on Tuesday. The company’s 50 day simple moving average is $22.60 and its 200 day simple moving average is $22.59. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. Phibro Animal Health Co. has a 1 year low of $12.07 and a 1 year high of $26.55. The stock has a market capitalization of $884.99 million, a PE ratio of 45.52, a P/E/G ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, sell-side analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be given a $0.12 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.20%. Phibro Animal Health’s dividend payout ratio is presently 100.00%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on PAHC. StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Saturday. Morgan Stanley lifted their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, Barclays lifted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Phibro Animal Health currently has an average rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.